Psychedelic Therapy Blog

Educational articles covering psychedelic therapy research, MDMA-assisted therapy, psilocybin treatment developments, and ketamine therapy updates in California.

Why medication questions come up so often People interested in psilocybin or MDMA-assisted therapy frequently take antidepressants for depression, anxiety, PTSD, or related conditions. That raises practical questions: Can someone remain on their medication during a psychedelic treatment? Would the medicine change the experience? Is stopping an antidepressant necessary? There is no universal answer. The […]

The emotional burden of serious illness A diagnosis of cancer or another life-threatening illness can bring fear, grief, uncertainty, and profound questions about identity and meaning. Some patients experience persistent anxiety or depression even when they have strong medical and family support. Palliative care, counseling, psychiatric treatment, spiritual care, and support groups can all play […]

Why couples are interested in MDMA Relationship difficulties often involve fear, defensiveness, unresolved conflict, and trouble discussing painful experiences. Because MDMA has been studied for its effects on emotional processing and interpersonal openness, some couples wonder whether it could make difficult conversations feel safer or more productive. Interest is especially strong when one partner lives […]

Why alcohol use disorder is part of psychedelic research Alcohol use disorder is a medical condition characterized by difficulty controlling alcohol use despite harmful consequences. Treatment can involve behavioral therapies, medications, peer support, and attention to medical or psychiatric conditions that may occur alongside drinking. Because relapse and ongoing symptoms remain common, researchers continue to […]

Understanding complex PTSD Post-traumatic stress disorder can develop after a frightening or life-threatening experience. For some people, however, trauma is not a single event. It may involve years of childhood abuse, domestic violence, exploitation, or repeated exposure to danger. When trauma is prolonged and difficult to escape, the effects can extend beyond fear and intrusive […]

San Diego residents interested in psychedelic medicine do not currently have routine clinical access to FDA-approved psilocybin or MDMA-assisted therapy. Ketamine, however, is already being used in mental healthcare, and a number of treatment models have developed around it. That makes choosing a provider more complicated than simply finding the nearest clinic. Ketamine treatment can […]

Ketamine occupies an unusual position in the psychedelic therapy conversation. Unlike psilocybin and MDMA, ketamine is already an established medication with legitimate medical uses. Certain ketamine-based approaches are currently used in mental healthcare, making it one of the few treatments commonly discussed alongside psychedelics that patients can actually encounter in clinical settings today. Interest has […]

Psychedelic integration has become a common term as interest in psychedelic experiences has increased, but the phrase is not always used consistently. At its simplest, integration refers to the process of reflecting on an experience and considering how it relates to a person’s emotions, relationships, behavior, values, or mental health. Some licensed therapists offer integration-focused […]

PTSD has been at the center of the modern conversation about MDMA-assisted therapy. That relationship is not accidental. Researchers have investigated whether MDMA, when administered within a structured therapeutic protocol, can help some people engage with traumatic memories without becoming as overwhelmed by fear, avoidance, or emotional distress. The research has attracted considerable attention, particularly […]

If psilocybin becomes an FDA-approved treatment, it is unlikely to be appropriate for everyone who is interested in trying it. Clinical research on psilocybin uses screening procedures designed to identify participants who fit the condition being studied while reducing avoidable medical and psychiatric risks. An eventual approved treatment would have its own requirements, which cannot […]